With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares that leading brokers have named as buys this week are listed below. Hereâs why they are bullish on them:
Coles Group Ltd (ASX: COL)
According to a note out of Citi, its analysts have retained their buy rating and $20.20 price target on this supermarket operatorâs shares. This follows the release of a quarterly update from Coles last week, which came in a touch ahead of Citiâs forecasts. The broker believes that the companyâs private label offering has been a key driver of this outperformance and appears to believe the trend can continue. The Coles share price is fetching $18.29 this afternoon.
Coronado Global Resources Inc (ASX: CRN)
A note out of Goldman Sachs reveals that its analysts have retained their buy rating on this coal minerâs shares with an increased price target of $2.20. This follows the release of a quarterly update that was in-line with expectations. Goldman continues to see Coronado as a great option due to its strong free cash flow and dividend yield, as well as a supportive met coal market on supply risks and Chinaâs reopening. The Coronado Global share price is trading at $1.68 today.
ResMed Inc. (ASX: RMD)
Analysts at Goldman Sachs have also retained their buy rating on this sleep treatment companyâs shares with an improved price target of $39.60. This follows the release of a solid quarterly update from ResMed last week. Goldman was pleased with what it saw and has upgraded its revenue and earnings estimates through to FY 2026. The broker also continues to see a long-duration runway of HSD organic growth and highlights that its shares trade on lower than normal multiples. The ResMed share price is trading at $35.84 on Monday.
The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now…
See The 5 Stocks
*Returns as of April 3 2023
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- Why Perenti, Pointsbet, ResMed, and Telix shares are rising today
- 5 things to watch on the ASX 200 on Monday
- Coles share price wobbles despite 7% sales revenue growth
- ResMed share price higher on Q3 ‘solid beat’
- Better ASX 200 healthcare share: CSL vs. Resmed
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed. The Motley Fool Australia has positions in and has recommended Coles Group and ResMed. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/PH5v8JZ
Stock Pick 